Biofrontera Inc. Common Stock
Market Cap
13M
Short interest (Apr 30)
0.7%
Net Short (Jun 03 ): -0.1%
Borrow Fee
1.36%
↓ 43.4%
Available Shares
700K
↑ 5.0%
Price Chart
Company Overview
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.